Bildkälla: Stockfoto

Medivir: Positive Phase II Results, Still Unclear Outlook for Skin Oncology Asset

Redeye comments on the positive update for remetinostat in basal cell carcinoma.

Redeye comments on the positive update for remetinostat in basal cell carcinoma.
Börsvärldens nyhetsbrev
ANNONSER